BioSpace News Archive

Biotech Bay

Significant Reduction in Pathogenic Gut Bacteria Lowers Potential for Infection Risk in Infants Fed B. infantis EVC001

Evolve BioSystems Demonstrates 93 Percent Drop in Common Pathogens such as E. coli, C. difficile

July 18, 2018
·
3 min read
Genetown

SilverCloud Health Launches First Evidence-Based Online Solution Focused On Assisting Those With Mental Health And Financial Difficulties

SilverCloud Health launched the first to-market online therapeutic solution to address the global crisis relating to individuals caught in the vicious cycle of financial difficulties and mental health challenges.

July 18, 2018
·
3 min read
Business

Cronos Group Inc. Announces Capacity Expansion with Premier Greenhouse Expert

Cronos Group Inc. is pleased to announce that it has entered into a joint venture partnership with a group of investors led by Bert Mucci

July 18, 2018
·
7 min read
Policy

The World Health Organization Recognizes New Antifungal Class by Granting “ibrexafungerp” to SCYNEXIS as the International Non-Proprietary Name for SCY-078

New WHO INN stem "-fungerp” signifies a novel class of antifungals Novel generic name highlights the unique attributes of SCY-078 and its potential to address significant unmet needs across multiple indications

July 18, 2018
·
5 min read
Biotech Beach

Alcala Labs First to Integrate Neoteryx’s VAMS™ Technology for Substance Abuse Monitoring

Dried blood samples replace urine monitoring for patients of alcohol and opioid addiction

July 18, 2018
·
3 min read
Business

Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK

Sterigenics’ continued investment in global network expansions supports growing MedTech and pharmaceutical customer needs

July 18, 2018
·
4 min read
Drug Development

Hyleukin-7 Selected as a Korea Drug Development Fund (KDDF) Project for Combination Trial with Merck’s KEYTRUDA®

Genexine will conduct a phase 1b/2 clinical trial to investigate the safety and efficacy of Hyleukin-7 treatment in combination with Merck’s anti PD-1 therapy, KEYTRUDA® in patients with triple-negative breast cancer.

July 18, 2018
·
4 min read
Business

Clovis Oncology to Announce Second Quarter 2018 Financial Results and Host Webcast Conference Call on August 1

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2018 financial results on Wednesday, August 1, 2018

July 18, 2018
·
1 min read
BioCapital

Startup Neuraly Raises $36M to Bring Potential Disease-Modifying Treatments to Patients with Parkinson’s Disease

Research published in Nature Medicine demonstrates protection against dopamine loss and behavioral deficits associated with Parkinson’s disease

July 18, 2018
·
3 min read
Biotech Beach

Ra Medical Systems Files Registration Statement for Proposed Initial Public Offering

Ra Medical Systems has applied to list its common stock on the NYSE under the ticker symbol “RMED.”

July 18, 2018
·
1 min read